Format
Sort by
Items per page

Send to

Choose Destination

Search results

Items: 8

1.
2.

Vitamin E Phosphate Nucleoside Prodrugs: A Platform for Intracellular Delivery of Monophosphorylated Nucleosides.

Daifuku R, Koratich M, Stackhouse M.

Pharmaceuticals (Basel). 2018 Feb 6;11(1). pii: E16. doi: 10.3390/ph11010016.

3.
4.

Mechanistic population pharmacokinetics of total and unbound paclitaxel for a new nanodroplet formulation versus Taxol in cancer patients.

Bulitta JB, Zhao P, Arnold RD, Kessler DR, Daifuku R, Pratt J, Luciano G, Hanauske AR, Gelderblom H, Awada A, Jusko WJ.

Cancer Chemother Pharmacol. 2009 May;63(6):1049-63. doi: 10.1007/s00280-008-0827-2. Epub 2008 Sep 13.

PMID:
18791718
5.

Multiple-pool cell lifespan models for neutropenia to assess the population pharmacodynamics of unbound paclitaxel from two formulations in cancer patients.

Bulitta JB, Zhao P, Arnold RD, Kessler DR, Daifuku R, Pratt J, Luciano G, Hanauske AR, Gelderblom H, Awada A, Jusko WJ.

Cancer Chemother Pharmacol. 2009 May;63(6):1035-48. doi: 10.1007/s00280-008-0828-1. Epub 2008 Sep 13.

PMID:
18791717
6.

KP-1212/1461, a nucleoside designed for the treatment of HIV by viral mutagenesis.

Harris KS, Brabant W, Styrchak S, Gall A, Daifuku R.

Antiviral Res. 2005 Jul;67(1):1-9.

PMID:
15890415
7.

Viral error catastrophe by mutagenic nucleosides.

Anderson JP, Daifuku R, Loeb LA.

Annu Rev Microbiol. 2004;58:183-205. Review.

PMID:
15487935
8.

Supplemental Content

Loading ...
Support Center